
Virtus Convertible & Income 2024 Target Term Fund is a closed ended balanced mutual fund launched and managed by Allianz Global Investors U.S. LLC. The fund invests in the public equity and fixed incomes markets of the United States. It invests in stocks of companies operating across diversified sectors. For its fixed income, the fund invests in income producing debt instruments and Senior Secured Loans. For its equity, it invests in convertible securities. The fund primarily invests in fixed income securities with a primary focus on below "BBB-" rated securities. It employs a fundamental analysis with a bottom-up stock picking approach to create its portfolio. Virtus Convertible & Income 2024 Target Term Fund was formed on June 30, 2017 and is domiciled in United States.
Virtus Convertible & Income 2024 Target Term Fund trades as CBH on NYSE. The company is classified in Financial Services / Asset Management - Income and reports in USD.
The current profile places the business in Asset Management - Income. This section is intended to summarize the operating segments, products, geographies, and main revenue lines from official filings.
Detailed operating-segment data is not available for this symbol yet.
Use this area for management strategy, capital allocation priorities, target markets, and measurable goals from the latest annual report or investor presentation.
The app now provides the structure, but exact strategic claims should come from official company documents before being treated as a finished investment thesis.
Virtus Convertible & Income 2024 Target Term Fund can be compared against peers such as BNY Mellon Alcentra Global Credit Income 2024 Target Term Fund, Inc., Invesco High Income 2023 Target Term Fund, Insight Select Income Fund, Ivy Funds - Delaware Ivy High Income Opportunities Fund, Pioneer Municipal High Income Fund, Inc., Pioneer Municipal High Income Opportunities Fund, Inc..
A complete thesis should compare growth, margins, balance-sheet risk, valuation multiples, and market position against direct competitors.
Current signals to investigate include market capitalization of $167.75M, beta of 0.49, and return on equity of N/A.
This section should be validated with evidence such as durable margins, brand strength, regulation, switching costs, cost advantage, distribution, or technology.
Key risks should include financial leverage, cyclicality, customer concentration, regulatory exposure, currency risk, and execution risk.
CBH currently shows total debt of N/A and beta of 0.49. Missing data should be treated as a research gap, not as low risk.
Production-capacity detail is not available as structured data yet. For industrial, defense, semiconductor, or real-estate companies, this should be reviewed from annual reports and investor presentations.
No structured backlog field is available yet. If the company reports backlog, review the relevant filing section before adding it to the thesis.
Use this section for major contracts, product launches, construction projects, acquisitions, or strategic programs that can materially affect valuation.
No recent SEC-style filings are available for this symbol yet.
Customer concentration is not available as structured data here. Add it from official filings when a company discloses material customers or revenue concentration.
Supplier concentration and critical supply-chain dependencies are not available as structured data here. This should be researched from annual reports and risk disclosures.
Company website: https://www.us.allianzgi.com/Products/pages/743.aspx?ShareClassCode=ARTIFICIAL
For US-listed stocks, verify the thesis against official filings, earnings call transcripts, and company investor relations materials.